Catalog

Advanced Echo 2023
Online
Added:02/22/2023 2:43 PM

This course features 49 presentations compiled from Echo Hawaii and State-of-the-Art Echocardiography. This course also includes board style questions for a majority of the presentations.
CME/MOC Credits: 13.75 AMA PRA Category 1 Credits™
Release Date: March 27, 2023
Activity Expiration Date: March 27, 2024 - CME/MOC must be claimed by this date.
STATE-OF-THE-ART ECHOCARDIOGRAPHY LECTURES
AI and Echocardiography
S. Lester
Quantitation of Ventricular Function
R. Lang
Contrast Echocardiography: Impact on Diagnosis and Outcome
J. Oh
Stress Echocardiography is Still Alive
W. Zoghbi
Cases to Illustrate When Aortic Stenosis Gradient and Area Do Not Match
M. Saric
What Should A Successful TAVR Look Like
R. Jain
Degenerated Bio Prosthesis, Valve-in-Valve
N. Faza
Mitral Regurgitation, Etiology and Quantification
W. Zoghbi
Mitra Clip Measurements
N. Faza
Pathologies of Mitral Valve
S. Mankad
Pathologies of Tricuspid Valve
S. Mankad
Tricuspid Valve Repair: The New Frontier
N. Faza
LAA Occluder Device, Measurement
M. Saric
Measuring Normal Function of Prosthetic Valves
W. Zoghbi
Aortic Regurgitation Illustrative Cases
M. Malahfji
Native and Prosthetic Valve Endocarditis
M. Saric
Learn Clinical Diastology With Cases
J. Oh
Amyloid and Constriction
J. Oh
Stress Cardiomyopathy
M. Malahfji
Systemic Illness and The Heart
S. Lester
Pulmonary Hypertension: Optimal Evaluation
M. Mukherjee
RV Strain: Cases to Illustrate How
S. Lester
Clinical Examples of Utility Of GLS
S. Mankad
Utility of LA Strain: Case Examples
M. Mukherjee
Cardio Oncology: Case Examples
Normal and Abnormal LVAD Cases
M. Christensen
Pulmonary Embolism and RV Strain
M. Mukherjee
ECHO HAWAII LECTURES
Physiology of Diastole: What are We Trying to Measure?
G. Scalia
Physiology of Systole: What are We Really Trying to Measure?
J. Lindner
Intro to Strain Imaging: How does GLS add to EF?
S. De
A Primer on Adult Congenital Echoes
A. De Freitas
Assessing the RV - Role of Strain and 3D
M. Saric
Echo in Beside Care: COVID and Beyond
S. McCartney
Strain in the Assessment of Cardiomyopathies
J. Oh
The Future of Echo: AI and Machine Learning
J. Thomas
Chest Pain in the ER: Which Test?
J. Lindner
Complications of MI: Echo has the Answer
S. McCartney
The Future of Echo: Advanced Applications of Contrast
J. Lindner
Strategies to Make Your Lab Excellent
M. Jankowski
Assessment of Atrial Function: What is the Role of Strain?
G. Scalia
Top 5 Situations Where I Find Strain is Helpful
V. Rigolin
Septal Defects You Don't Want to Close
A. de Freitas
Quantification of Stenosis: Avoid These Pitfalls
W. Armstrong
Starting an Interventional Echo Program: Training, Technique, & Economics
S. Little
3D Assessment of the Cardiac Valves
G. Scalia
Interventions for MR in Heart Failure
G. Scalia
MitraClip: Who is it for? How is it Guided?
M. Saric
The Future of Echo: The Brave New World
S. Little
Eisenmenger's Echo in the Middle of the Night
A. de Freitas
A Systematic Approach to Multi-Valve Disease
J. Thomas
Exercise Echo and Strain to Time Intervention in Valvular Heart Disease
V. Rigolin
Improving source of Embolus Exams: The Science of Saline Contrast
W. Armstrong
TEE in Emergent Situations
S. McCartney
Athlete's Heart: Separating Abnormal from Supraphysiologic
L. Gillam
Use of Echo in Pulmonary Hypertension
G. Scalia
Credits awarded per Session. See individual Sessions for further details.
Credits awarded
Type
Name
Sub type
Value
Certificate awarded

About this item

This course features 49 presentations compiled from Echo Hawaii and State-of-the-Art Echocardiography. This course also includes board style questions for a majority of the presentations. 

CME/MOC Credits: 13.75 AMA PRA Category 1 Credits™ 

Release Date: March 27, 2023
Activity Expiration Date: March 27, 2024 - CME/MOC must be claimed by this date.

STATE-OF-THE-ART ECHOCARDIOGRAPHY LECTURES

  • AI and Echocardiography
    S. Lester
  • Quantitation of Ventricular Function
    R. Lang
  • Contrast Echocardiography: Impact on Diagnosis and Outcome
    J. Oh
  • Stress Echocardiography is Still Alive
    W. Zoghbi
  • Cases to Illustrate When Aortic Stenosis Gradient and Area Do Not Match
    M. Saric
  • What Should A Successful TAVR Look Like
    R. Jain
  • Degenerated Bio Prosthesis, Valve-in-Valve
    N. Faza
  • Mitral Regurgitation, Etiology and Quantification
    W. Zoghbi
  • Mitra Clip Measurements
    N. Faza
  • Pathologies of Mitral Valve
    S. Mankad
  • Pathologies of Tricuspid Valve
    S. Mankad
  • Tricuspid Valve Repair: The New Frontier
    N. Faza
  • LAA Occluder Device, Measurement
    M. Saric
  • Measuring Normal Function of Prosthetic Valves
    W. Zoghbi
  • Aortic Regurgitation Illustrative Cases
    M. Malahfji
  • Native and Prosthetic Valve Endocarditis
    M. Saric
  • Learn Clinical Diastology With Cases
    J. Oh
  • Amyloid and Constriction
    J. Oh
  • Stress Cardiomyopathy
    M. Malahfji
  • Systemic Illness and The Heart
    S. Lester
  • Pulmonary Hypertension: Optimal Evaluation
    M. Mukherjee
  • RV Strain: Cases to Illustrate How
    S. Lester
  • Clinical Examples of Utility Of GLS
    S. Mankad
  • Utility of LA Strain: Case Examples
    M. Mukherjee
  • Cardio Oncology: Case Examples
  • Normal and Abnormal LVAD Cases
    M. Christensen
  • Pulmonary Embolism and RV Strain
    M. Mukherjee

ECHO HAWAII LECTURES

  • Physiology of Diastole: What are We Trying to Measure?
    G. Scalia
  • Physiology of Systole: What are We Really Trying to Measure?
    J. Lindner
  • Intro to Strain Imaging: How does GLS add to EF?
    S. De
  • A Primer on Adult Congenital Echoes
    A. De Freitas
  • Assessing the RV - Role of Strain and 3D
    M. Saric
  • Echo in Beside Care: COVID and Beyond
    S. McCartney
  • Strain in the Assessment of Cardiomyopathies
    J. Oh
  • The Future of Echo: AI and Machine Learning
    J. Thomas
  • Chest Pain in the ER: Which Test?
    J. Lindner
  • Complications of MI: Echo has the Answer
    S. McCartney
  • The Future of Echo: Advanced Applications of Contrast
    J. Lindner
  • Strategies to Make Your Lab Excellent
    M. Jankowski
  • Assessment of Atrial Function: What is the Role of Strain?
    G. Scalia
  • Top 5 Situations Where I Find Strain is Helpful
    V. Rigolin
  • Septal Defects You Don't Want to Close
    A. de Freitas
  • Quantification of Stenosis: Avoid These Pitfalls
    W. Armstrong
  • Starting an Interventional Echo Program: Training, Technique, & Economics
    S. Little
  • 3D Assessment of the Cardiac Valves
    G. Scalia
  • Interventions for MR in Heart Failure
    G. Scalia
  • MitraClip: Who is it for? How is it Guided?
    M. Saric
  • The Future of Echo: The Brave New World
    S. Little
  • Eisenmenger's Echo in the Middle of the Night
    A. de Freitas
  • A Systematic Approach to Multi-Valve Disease
    J. Thomas
  • Exercise Echo and Strain to Time Intervention in Valvular Heart Disease
    V. Rigolin
  • Improving source of Embolus Exams: The Science of Saline Contrast
    W. Armstrong
  • TEE in Emergent Situations
    S. McCartney
  • Athlete's Heart: Separating Abnormal from Supraphysiologic
    L. Gillam
  • Use of Echo in Pulmonary Hypertension
    G. Scalia

Course/Activity Information

Learning Objectives

Upon completion of this program, participants will be better able to:

  • Integrate echocardiographic information in clinical decision making.
  • Assess ventricular and valvular function using Doppler hemodynamics.
  • Describe Doppler assessment of diastolic function/dysfunction.
  • Explain new advances in the echocardiographic assessment of left and right ventricular function, including strain and 3D.
  • Integrate echocardiographic assessment of cardiomyopathies and systemic diseases in patient management.
  • Define clinical uses of TEE and 3D echocardiography.
  • Recognize how echocardiography is used to help manage patients with ischemic heart disease.
  • Recognize the role of echo contrast and be able to incorporate its use in the echo laboratory.
  • Integrate echo information in the management of complex valvular heart disease.

Disclosure:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

  • William F. Armstrong, MD

  • Marissa Cristensen, RDCS

  • Andrew de Freitas, MD

  • Nadeen Faza, MD, FASE

  • Renuka Jain, MD, FASE

  • Roberto M. Lang, MD, FASE

  • Steven Lester, MD, FASE

  • Stephen H. Little, MD, FASE

  • Sunil Mankad, MD, FASE

  • Monica Mukherjee, MD, MPH

  • Vera Rigolin, MD, FASE

  • William Zoghbi, MD, FASE

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

  • Sabe De, MD, FASE - Bayer, Astra Zeneca, Pfizer, Alnylam, Novartis (Speaker/Speaker’s Bureau, Consultant/Advisor); Janssen Canada, Inc., (Speaker/Speaker’s Bureau)

  • Linda D. Gillam, MP, MPH, FASE - Bracco Imaging, Edwards Lifescience, Medtronic, Philips (Consultant or Advisor); Abbott, Edwards Lifesciences, Medtronic (Research Support/Funding)

  • Madeline Jankowski, RDCS, ACS, FASE - Bristol Myers Squibb, Caption Health, Echo IQ (Consultant/Advisor); Bristol Myers Squibb, Caption Health (Educator/Honoraria)

  • Jonathan R. Lindner, MD, FASE - Lantheus Medical Imaging, Philips, NASA, NIH (Research Support/Funding); BioMarin Pharma, Lantheus Medical Imaging, Cytokinetics, NovaPulse, Vibrato Inc. (Consultant/Advisor)

  • Maan Malahfji, MD, FACC - Guerbet (Research Funding)

  • Sharon McCartney, MD, FASE - Humacyte (Consultant/Advisor)

  • Jae K. Oh, MD, FASE - Anuman (Royalties/Patent Beneficiary); Medtronic (Consultant/Advisor); Rednvia (Research Support/ Funding); UpToDate (Editor)

  • Muhamed Saric, MD, PhD, FASE - Abbott, Boston Scientific, Medtronic (Speaker/Speaker’s Bureau); Siemens (Consultant/ Advisor)

  • Gregory Scalia, MBBS, FASE - Abbott, Edwards, Philips, GE (Educator/Honoraria)

  • James Thomas, MD, FASE - Abbott, Caption Health, egnite, GE Healthcare (Educator/Honoraria)

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.

Other information

  • Training Hours: 13.75
  • Additional Charges May Apply

    Ratings and reviews

    Close
    Shopping Cart
    Total:  Close

    Loading Shopping Cart Items...